Cargando…
Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
PURPOSE: The venous-to-arterial carbon dioxide partial pressure difference (CO(2) gap) has been reported to be a sensitive indicator of cardiac output adequacy. We aimed to assess whether the CO(2) gap can predict postoperative adverse outcomes after cardiac surgery. METHODS: A retrospective study w...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785330/ https://www.ncbi.nlm.nih.gov/pubmed/33403551 http://dx.doi.org/10.1007/s12630-020-01881-4 |
_version_ | 1783632419453140992 |
---|---|
author | Huette, Pierre Beyls, Christophe Mallat, Jihad Martineau, Lucie Besserve, Patricia Haye, Guillaume Guilbart, Mathieu Dupont, Hervé Guinot, Pierre-Grégoire Diouf, Momar Mahjoub, Yazine Abou-Arab, Osama |
author_facet | Huette, Pierre Beyls, Christophe Mallat, Jihad Martineau, Lucie Besserve, Patricia Haye, Guillaume Guilbart, Mathieu Dupont, Hervé Guinot, Pierre-Grégoire Diouf, Momar Mahjoub, Yazine Abou-Arab, Osama |
author_sort | Huette, Pierre |
collection | PubMed |
description | PURPOSE: The venous-to-arterial carbon dioxide partial pressure difference (CO(2) gap) has been reported to be a sensitive indicator of cardiac output adequacy. We aimed to assess whether the CO(2) gap can predict postoperative adverse outcomes after cardiac surgery. METHODS: A retrospective study was conducted of 5,151 patients from our departmental database who underwent cardiac surgery from 1 January 2008 to 31 December 2018. Lactate level (mmol·L(−1)), central venous oxygen saturation (ScVO(2)) (%), and the venous-to-arterial carbon dioxide difference (CO(2) gap) were measured at intensive care unit (ICU) admission and on days 1 and 2 after cardiac surgery. The following postoperative adverse outcomes were collected: ICU mortality, hemopericardium or tamponade, resuscitated cardiac arrest, acute kidney injury, major bleeding, acute hepatic failure, mesenteric ischemia, and pneumonia. The primary outcome was the presence of at least one postoperative adverse outcome. Logistic regression was used to assess the association between ScVO(2), lactate, and the CO(2) gap with adverse outcomes. Their diagnostic performance was compared using a receiver operating characteristic (ROC) curve. RESULTS: There were 1,933 patients (38%) with an adverse outcome. Cardiopulmonary bypass (CPB) parameters were similar between groups. The CO(2) gap was slightly higher for the “adverse outcomes” group than for the “no adverse outcomes” group. Arterial lactate at admission, day 1, and day 2 was also slightly higher in patients with adverse outcomes. Central venous oxygen saturation was not significantly different between patients with and without adverse outcomes. The area under the ROC curve to predict outcomes after CPB for the CO(2) gap at admission, day 1, and day 2 were 0.52, 0.55, and 0.53, respectively. CONCLUSION: After cardiac surgery with CPB, the CO(2) gap at ICU admission, day 1, and day 2 was associated with postoperative adverse outcomes but showed poor diagnostic performance. |
format | Online Article Text |
id | pubmed-7785330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-77853302021-01-06 Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study Huette, Pierre Beyls, Christophe Mallat, Jihad Martineau, Lucie Besserve, Patricia Haye, Guillaume Guilbart, Mathieu Dupont, Hervé Guinot, Pierre-Grégoire Diouf, Momar Mahjoub, Yazine Abou-Arab, Osama Can J Anaesth Reports of Original Investigations PURPOSE: The venous-to-arterial carbon dioxide partial pressure difference (CO(2) gap) has been reported to be a sensitive indicator of cardiac output adequacy. We aimed to assess whether the CO(2) gap can predict postoperative adverse outcomes after cardiac surgery. METHODS: A retrospective study was conducted of 5,151 patients from our departmental database who underwent cardiac surgery from 1 January 2008 to 31 December 2018. Lactate level (mmol·L(−1)), central venous oxygen saturation (ScVO(2)) (%), and the venous-to-arterial carbon dioxide difference (CO(2) gap) were measured at intensive care unit (ICU) admission and on days 1 and 2 after cardiac surgery. The following postoperative adverse outcomes were collected: ICU mortality, hemopericardium or tamponade, resuscitated cardiac arrest, acute kidney injury, major bleeding, acute hepatic failure, mesenteric ischemia, and pneumonia. The primary outcome was the presence of at least one postoperative adverse outcome. Logistic regression was used to assess the association between ScVO(2), lactate, and the CO(2) gap with adverse outcomes. Their diagnostic performance was compared using a receiver operating characteristic (ROC) curve. RESULTS: There were 1,933 patients (38%) with an adverse outcome. Cardiopulmonary bypass (CPB) parameters were similar between groups. The CO(2) gap was slightly higher for the “adverse outcomes” group than for the “no adverse outcomes” group. Arterial lactate at admission, day 1, and day 2 was also slightly higher in patients with adverse outcomes. Central venous oxygen saturation was not significantly different between patients with and without adverse outcomes. The area under the ROC curve to predict outcomes after CPB for the CO(2) gap at admission, day 1, and day 2 were 0.52, 0.55, and 0.53, respectively. CONCLUSION: After cardiac surgery with CPB, the CO(2) gap at ICU admission, day 1, and day 2 was associated with postoperative adverse outcomes but showed poor diagnostic performance. Springer International Publishing 2021-01-06 2021 /pmc/articles/PMC7785330/ /pubmed/33403551 http://dx.doi.org/10.1007/s12630-020-01881-4 Text en © Canadian Anesthesiologists' Society 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Reports of Original Investigations Huette, Pierre Beyls, Christophe Mallat, Jihad Martineau, Lucie Besserve, Patricia Haye, Guillaume Guilbart, Mathieu Dupont, Hervé Guinot, Pierre-Grégoire Diouf, Momar Mahjoub, Yazine Abou-Arab, Osama Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
title | Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
title_full | Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
title_fullStr | Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
title_full_unstemmed | Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
title_short | Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
title_sort | central venous-to-arterial co(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study |
topic | Reports of Original Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785330/ https://www.ncbi.nlm.nih.gov/pubmed/33403551 http://dx.doi.org/10.1007/s12630-020-01881-4 |
work_keys_str_mv | AT huettepierre centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT beylschristophe centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT mallatjihad centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT martineaulucie centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT besservepatricia centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT hayeguillaume centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT guilbartmathieu centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT dupontherve centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT guinotpierregregoire centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT dioufmomar centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT mahjoubyazine centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy AT abouarabosama centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy |